Pathogenesis and treatment of dyskalemia in maintenance hemodialysis and CAPD

Electrolyte and Blood Pressure

Volumn 4, Issue 1, 2006, Pages 47-52

  Kim, Ho Jung ^a,b  

^a Hanyang University   (South Korea)

^b Hanyang University Guri Hospital   (South Korea)

Author keywords

Continuous ambulatory peritoneal dialysis; Hemodialysis; Hyperkalemia; Hypokalemia

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; BISACODYL; CHOLINERGIC RECEPTOR STIMULATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; GLUCONATE CALCIUM; GLUCOSE; ICODEXTRIN; INSULIN; MINERALOCORTICOID; POTASSIUM; RESIN; SALBUTAMOL; SPIRONOLACTONE;

CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSATE; DIET SUPPLEMENTATION; ELECTROLYTE DISTURBANCE; HEMODIALYSIS; HOMEOSTASIS; HUMAN; HYPERKALEMIA; HYPOKALEMIA; INCIDENCE; KIDNEY FAILURE; PATHOGENESIS; POTASSIUM INTAKE; POTASSIUM METABOLISM; PREVALENCE; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 33748761405     PISSN: 17385997     EISSN: None     Source Type: Journal    
DOI: 10.5049/EBP.2006.4.1.47     Document Type: Review

References (26)

1. Sherman RA, Hwang ER, Bernholc AS, Eisinger RP: Variability in potassium removal by hemodialysis. Am J Nephrol 6 284-288, 1986
2. Szeto CC, Chow KA, Kwan BCH Leung CB, Chung KY, Law MC Kam-Tao: Hypokalemia in Chinese peritoneal dialysis patients: Prevalence and prognostic implication. Am J Kidney Dis 46:128-135, 2005
3. Amici G, Orrasch M, Rin GD, Bocci C: Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 17:81-85, 2001
4. Bastl C, Hayslett JP, Binder HJ: Increased large intestinal secretion of potassium in renal insufficiency. Kidney Int 12:9-16, 1977
5. Weiner D, Wingo CS: Hyperkalemia: a potential silent killer. J Am Soc Nephrol 9:1535-1545, 1998
6. Kim JH, Kahng KW, Kim JH, Kim HJ, Park CH, Kang CM, Park HC: The survival rate and causes of death in patients with chronic renal failure on hemodialysis. Korean J Med 44:294-300, 1993
7. Cho HD, Choi CR, Choi SI, Kang TY, Lee DK, Ryu JH, Han SW, Kim HJ: The Analysis of Causes and Treatments of Hyperkalemia. Korean J Nephrol 20:882-889, 2001
8. Castellino P, Bia MJ, DeFronzo RA: Adrenergic modulation of potassium metabolism in uremia. Kidney Int 37:793-798, 1990
9. Nowicki M, Miszczak-Kuban J: Nonselective beta-adrenergic blockade augments fasting hyperkalemia in hemodialysis patients. Nephron 91:222-227, 2002
10. Lee JU, Lee OY, Yang SC, Han DS, Sohn JH, Kim SK, Kim HJ, Koh HK, Jung JH, Nam SW, Paik IK, Lee CB: The influence of nonselective beta-adrenergic blockade (carteolol) and ACE inhibitor (captopril) in plasma potassium on maintenance hemodialysis. Korean J Med 52:149-155, 1997
11. Knoll GA, Sahgal A, Nair RC, Graham J, Van Walraven C, Burns KD: Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. Am J Med 112:110-114, 2001
12. Hussain S, Dreyfus DE, Marcus RJ, Biederman RWW, McGill RL: Is spironolactone safe for dialysis patients? Nephrol Dial Transplant 18:2364-2368, 2003
13. Han SW, Won YW, Kim HJ: No impact of hyperkalemia with renin-angiotensin system blockades in maintenance hemodialysis patients [Abstract]. (Submitted to NDT 2006)
14. Blumberg A, Weidman P, Ferrari P: Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 41:369-374, 1992
15. Kim HJ: The combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 38:869-872, 1996
16. Kim HJ: Acute therapy with the combined regimen of bicarbonate and beta-2 agonist (salbutamol) in chronic renal failure patients. J Korean Med Sci 12:111-116, 1997
17. Allon M, Copkney C: Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 38:869-872, 1990
18. Choi CR, Cho HD, Kang TY, Lee JS, Han H, Jung CI, Lee DK, Ryu JH, Han SW, Kim HJ: Pseudo-hyperkalemia on Maintenance Hemodialysis. Korean J Nephrol 20:842-850, 2001
19. Kim HJ, Han SW: Therapeutic approach to hyperkalemia. Nephron 92(suppl 1):33-40, 2002
20. Mathialahan T, Sandle GI: Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease. Nephrol Dial Transplant 18:341-347, 2003
21. Furuya R, Kumagai H, Sakao T, Maruyama Y. Hishida A: Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis. Nephron 92 576-581, 2002
22. Serra A, Uehlinger DE, Ferrari P, Dick B, Frey BM, Frey FJ, Vogt B: Glycyrrhetinic acid decreases plasma potassium concentrations in patients with anuria. J Am Soc Nephrol 13:191-196, 2002
23. Kim HJ, Han SW, Choi HY, Lee HY: Comparison of serum potassium (K) profile between the conven tional glucose solution and icodextrin in CAPD [Abstract]. (submitted to ERA-EDTA 2006)
24. Kim HJ, Kim JY, Son BK, Lee KW: High prevalence of hypokalemia associated with underlying malnutrition and sustained dialysate K loss in CAPD patients on admission [Abstract]. J Am Soc Nephrol 10:317. 1999
25. Tziviskou E, Musso C, Bellizzi V, Khandelwal M, Wang T, Savaj S, Oreopoulos DG: Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: One center's experience and review of the literature. Int Urol Nephrol 35:429-434, 2003
26. Kim HJ, Park IG: Acute potassium repletion by intraperitoneal administration in hypokalemic CAPD patients [Abstract]. ERA-EDTA 266A, 1997